Exciting product pipeline for us! What’s good though is that we already have a heart product FDA approved — the Imbio CAC scoring product was approved only a few months before the acquisition in June 2023. And getting the EU CE mark for CAC scoring is also on the cards, per previous presentations.
https://www.accessdata.fda.gov/cdrh_docs/pdf23/K230112.pdf
So we’re only just getting started marketing this..
Exciting product pipeline for us! What’s good though is that we...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
-0.010(1.89%) |
Mkt cap ! $213.4M | |||
| Open | High | Low | Value | Volume |
| 53.5¢ | 53.5¢ | 52.0¢ | $165.2K | 312.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 47244 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.5¢ | 19261 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |